Progress of Angiogenesis Signal Pathway and Antiangiogenic Drugs in Nasopharyngeal Carcinoma
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-12
Author(s):
Yunzhi Zhu, Yi Hu, Chengsheng Yang, Shipu Huang, Jianping Wen, Weiguo Huang and Shengjun Xiao*
Regulating miRNAs Expression by Resveratrol: Novel Insights based on Molecular Mechanism and Strategies for Cancer Therapy
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-21
Author(s):
Atoosa Keshavarzmotamed, Vahide Mousavi, Niloufar Masihipour, Atefe Rahmati, Rohollah Mousavi Dehmordi, Behrooz Ghezelbash, Mina Alimohammadi* and Alireza Mafi*
Are Purinergic Receptors Overlooked Targets in Hyperinflammatory Responses?
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-4
Author(s):
Paulo A. F. Pacheco and Robson Xavier Faria*
Hepatic Ischemia-reperfusion Injury: Protective Approaches and Treatment
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-10
Author(s):
Kuldeep Singh*, Jeetendra Kumar Gupta, Shivendra Kumar, Anurag, Soumyadip Mukherjee and Aman Patel
A Deeply Quiescent Subset of CML LSC depend on FAO yet Avoid Deleterious ROS by Suppressing Mitochondrial Complex I
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-19
Author(s):
Nyam-Osor Chimge, Min-Hsuan Chen, Cu Nguyen, Yuqi Zhao, Xiwei Wu, Paulina Garcia Gonzalez, Heather Ogana, Samantha Hurwitz, Jia-Ling Teo, Xiaolong Chen, Juan Du, Victor Jin, Yong-Mi Kim, Masaya Ono, Rafael J. Argüello and Michael Kahn*
The Regulatory Mechanism of Hypoxia-inducible Factor 1 and its Clinical Significance
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-10
Author(s):
Chun-Li Yin and Yu-Jie Ma*
Anticancer Properties of Baicalin against Breast Cancer and other Gynecological Cancers: Therapeutic Opportunities based on Underlying Mechanisms
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-10
Author(s):
Mohammad Hossein Pourhanifeh, Hossein Farrokhi-Kebria, Parsa Mostanadi, Tahereh Farkhondeh and Saeed Samarghandian*
A Review of the Dual Role of MicroRNA-21 in Cardiovascular Diseases: Risk Factor or a Potential Therapeutic Target
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-18
Author(s):
Amir Masoud Jafari-Nozad, Negin Rostami, Melika Esmaeili, Haniye Vahdati, Serajoddin Hosseini, Tahereh Farkhondeh and Saeed Samarghandian*
SGLT2 Inhibitors and Diabetic Kidney Disease: Targeting Multiple and Interrelated Signaling Pathways for Renal Protection
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-26
Author(s):
Georgios S. Papaetis*
Creatine in Cognitive Performance: A Commentary
Journal:
Current Molecular Pharmacology
Volume:
17
Page:
1-5
Author(s):
Jasper Okoro Godwin Elechi, Diana Marisol Abrego Guandique and Roberto Cannataro*